Sector News

ABB and Werum Team Up on Technology for Life Sciences Industry

September 29, 2015
Life sciences

The two will collaborate on integrating their respective DCS and MES offerings, bringing together control and production workflow for pharmaceutical companies.

ABB, known for its power and distributed control system (DCS) technologies for utility, transport and process industries, is further developing its expertise in the life sciences market with the announcement of a partnership with Werum IT Solutions, a maker of manufacturing execution systems (MES). The memorandum of understanding, announced this month, will unite the two in the development of a joint solution for pharmaceutical and biopharmaceutical companies.

The move comes at a time when government initiatives like the Food and Drug Administration’s Drug Supply Chain Security Act (DSCSA), and compliance with traceability regulations like 21 CFR part 11, are forcing life science companies to upgrade technology and best practices. Pharmaceutical companies are also contemplating a move from batch manufacturing to continuous process in the plant to rapidly process drugs from powder to tablet while using the same equipment for product development, clinical supply and commercial production—tasks typically done in batches at different stages.

Werum’s PAS-X MES software is designed specifically for life sciences, covering key areas in manufacturing such as process development, commercial production and packaging, and track and trace. The software supports all major processes for vaccines, biopharmaceuticals, solids, liquids and other manufacturing operations. By bringing the Werum and ABB offerings together, customers will have access to a full scope of engineering and validation capabilities, the companies said.

According to ABB officials, the combined offering strengthens ABB’s portfolio in these rapidly growing industries. And, customers will have a seamless DCS/MES solution for their automation needs.

“Our customers will benefit from integrated solutions paving the way towards the factory of the future,” added Rüdiger Schlierenkämper, CEO of Werum IT Solutions. “We look forward to working together with ABB on joint projects and developing new ideas together.”


Source: Automation World

comments closed

Related News

January 22, 2023

Sun Pharma to buy Concert Pharmaceuticals for $576m

Life sciences

Sun Pharmaceutical Industries has signed a definitive agreement to buy all outstanding shares of Concert Pharmaceuticals in a deal valued at $576m. Under the deal, the company will buy all shares of Concert common stock through a tender offer for $8.00 per share in cash upfront payment.

January 22, 2023

Novo Nordisk diabetes pill wins FDA approval for first-line use

Life sciences

The Food and Drug Administration on Thursday approved Novo Nordisk’s diabetes pill Rybelsus as an initial treatment to lower blood sugar levels, a label expansion that will allow it to compete more directly with other oral drugs from Merck & Co. and Eli Lilly.

January 22, 2023

Bayer feeling more heat from activist investors, this time from Bluebell

Life sciences

Since making an ill-advised $63 billion buy of Monsanto in 2018, Bayer has faced heaps of pressure from investors that have called for the company to oust its leadership and to restructure. Now comes new pressure from a familiar source. Bluebell Capital Partners has bought an undisclosed stake in the company and is agitating for a breakup, sources told Reuters.

How can we help you?

We're easy to reach